Integra LifeSciences IART Change in Deferred Revenue
Change in Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's change in deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's change in deferred revenue?
- Integra LifeSciences (IART) reported change in deferred revenue of -$630K in Q1 2026.
- How has Integra LifeSciences's change in deferred revenue changed year-over-year?
- Integra LifeSciences's change in deferred revenue decreased by 358.2% year-over-year, from $244K to -$630K.
- What is the long-term trend for Integra LifeSciences's change in deferred revenue?
- Over 3 years (2021 to 2025), Integra LifeSciences's change in deferred revenue has grown at a 395.2% compound annual growth rate (CAGR), from $28K to $3.4M.
- What does change in deferred revenue mean?
- Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.